mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
0.0062 |
0.9 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.005 |
0.9 |